Qvar is a brand-name inhaled medication that contains beclomethasone dipropionate as its active ingredient. It belongs to the respiratory-health class of drugs known as inhaled corticosteroids (ICS). Qvar is supplied as a 200 mcg capsule (cap) that is used with a specially designed dry-powder inhaler. In Hong Kong, Qvar is a prescription-only product regulated by the Hong Kong Department of Health and conforms to the standards set by the World Health Organization for inhaled corticosteroids.
Beclomethasone dipropionate is a synthetic glucocorticoid that exerts anti-inflammatory effects in the airways. After inhalation, the fine particles reach the bronchial tree, where the pro-drug is converted by lung enzymes into the active steroid. The activated molecule binds to intracellular glucocorticoid receptors, altering gene transcription and reducing the production of inflammatory mediators such as cytokines, prostaglandins, and leukotrienes.
Key pharmacologic features include:
Qvar is approved in Hong Kong for the maintenance treatment of asthma in patients who require regular anti-inflammatory therapy. It is not intended for immediate relief of acute bronchospasm. The medication helps:
For patients with chronic obstructive pulmonary disease (COPD), inhaled corticosteroids such as beclomethasone may be used as part of combination therapy, but Qvar’s specific label does not include COPD as an approved indication in Hong Kong.
Current peer-reviewed literature provides modest evidence that inhaled beclomethasone may be explored for:
These applications are not approved by regulatory agencies in Hong Kong. Off-label use should only occur under the supervision of a qualified healthcare professional, with a clear assessment of potential benefits and risks.
Tip: Rinsing the mouth with water and spitting out the fluid after each dose can reduce the risk of oral thrush.
If any of these symptoms develop, patients should seek medical attention promptly.
Because interaction data for Qvar are limited, patients should always inform their healthcare provider of all prescription medicines, over-the-counter products, herbal supplements, and vitamins they are taking.
Routine follow-up is essential to assess asthma control and detect potential side effects.
This article provides educational information about Qvar and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
If the inhaler is misplaced, obtain a replacement from your pharmacy as soon as possible. Do not share another person's inhaler, as dosage and technique requirements differ.
Yes. Keep the inhaler in your carry-on luggage, and bring a copy of the prescription or a doctor's note if required by airport security, especially for flights to countries with strict medication regulations.
Qvar capsules are white, opaque, and marked with the dosage strength (e.g., “200 mcg”) on one side. Other brands may use colored caps or different imprint codes, so verify the label before insertion.
No. Qvar capsules are specifically designed for the Qvar™ DPI device. Using them with a different inhaler may result in incorrect dosing or delivery failure.
Both are inhaled steroids that reduce airway inflammation, but they differ in particle size, propellant-free delivery, and dosing schedules. Clinical choice depends on individual response, device preference, and physician assessment.
Inhaled corticosteroids are generally not screened for in standard drug-testing panels. However, specialized tests could detect systemic steroids if present in high concentrations.
Once the inhaler is loaded with capsules, it is recommended to use the capsules within 30 days to ensure optimal dose delivery. Check the manufacturer’s instructions for exact guidance.
Spacers are designed for press-urized metered-dose inhalers, not dry-powder inhalers. Using a spacer with Qvar may impair drug dispersion and is therefore not advised.
A 200 mcg dose is often sufficient for mild to moderate asthma and reduces the risk of systemic side effects. Dosage is individualized based on symptom control and lung function results.
As of the latest regulatory updates, no generic beclomethasone dipropionate capsule identical to Qvar’s formulation is marketed in Hong Kong. Patients should discuss cost-saving alternatives with their healthcare provider.